Literature DB >> 6304435

Evaluation of and access to posterior orbital tumors.

J D Osguthorpe, R A Saunders, W Y Adkins.   

Abstract

Head and neck surgeons enter the peripheral orbit for the therapy and/or biopsy of the most common expanding lesions, i.e., thyroid ophthalmopathy, direct extension of paranasal disease, pseudotumor and metastases. It is in this space between the bony orbital walls and the extraocular muscle cone that a majority of primary orbital neoplasms occur. The four basic approaches to posterior orbital tumors are: lateral orbitotomy through the temporal fossa with a modified Kronlein procedure, medial orbitotomy utilizing a Lynch incision and lacriminal sac mobilization, superior orbitotomy via a Naffziger frontotemporal crainotomy, and inferior exposure/decompression through the maxillary sinus. Case examples of the former two approaches are presented. None of these standard procedures allows full exposure of the posterior orbit. A combined cranio-facial-orbital access to this region utilizing a modified maxillectomy and frontotemporal craniotomy is detailed.

Entities:  

Mesh:

Year:  1983        PMID: 6304435     DOI: 10.1288/00005537-198306000-00013

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Head and neck squamous cell carcinoma metastatic to the orbital apex.

Authors:  T A Day; D K Hoasjoe; R L Hebert; E Gonzalez; W Shockley; F J Stucker; A Nanda
Journal:  Skull Base Surg       Date:  1995

2.  Anteromedial approach to the orbit.

Authors:  H Deda; H C Ugur; I Yorulmaz; B Kucuk
Journal:  Skull Base       Date:  2001-11

3.  Orbital and paraorbital tumors-clinicopathological profile and surgical management.

Authors:  Somnath Saha; Vedula Padmini Saha; Sarbani Chattopadhyay
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2002-04

4.  Retrospective Case Analysis of Transnasal Endoscopic Resection of Benign Orbital Apex Tumors: Some Thoughts on Transnasal Endoscopic Surgery.

Authors:  Cheng Li; Yang Gao; Rongxin Chen; Chao Cheng; Pan Yin; Zhihui Zhang; Yinghao Wang; Yuekun Bao; Huan Ma; Jianbo Shi; Rong Lu
Journal:  J Ophthalmol       Date:  2021-02-13       Impact factor: 1.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.